MSL3
Basic information
Region (hg38): X:11758159-11775772
Previous symbols: [ "MSL3L1" ]
Links
Phenotypes
GenCC
Source:
- Basilicata-Akhtar syndrome (Strong), mode of inheritance: XL
- Basilicata-Akhtar syndrome (Strong), mode of inheritance: XL
- Basilicata-Akhtar syndrome (Definitive), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Basilicata-Akhtar syndrome | XL | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 30224647 |
ClinVar
This is a list of variants' phenotypes submitted to
- Basilicata-Akhtar syndrome (9 variants)
- Inborn genetic diseases (4 variants)
- not provided (2 variants)
- Global developmental delay (1 variants)
- X-linked neurodevelopmental delay, dysmorphism, and progressive neurological disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MSL3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 37 | 46 | ||||
nonsense | 10 | |||||
start loss | 0 | |||||
frameshift | 13 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 3 | 1 | 4 | |||
non coding | 5 | |||||
Total | 15 | 11 | 43 | 15 | 2 |
Variants in MSL3
This is a list of pathogenic ClinVar variants found in the MSL3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-11758268-G-A | Inborn genetic diseases | Uncertain significance (Nov 07, 2022) | ||
X-11758279-G-A | Inborn genetic diseases | Uncertain significance (May 31, 2023) | ||
X-11758324-G-A | MSL3-related disorder | Uncertain significance (Jul 16, 2023) | ||
X-11758727-C-T | MSL3-related disorder | Uncertain significance (Mar 07, 2023) | ||
X-11758742-C-T | Inborn genetic diseases | Likely benign (Aug 22, 2022) | ||
X-11758803-C-T | Likely benign (Apr 01, 2023) | |||
X-11760438-G-C | Basilicata-Akhtar syndrome | Uncertain significance (-) | ||
X-11760446-G-C | Uncertain significance (Oct 25, 2022) | |||
X-11760483-A-C | Uncertain significance (Dec 05, 2023) | |||
X-11760495-G-A | Uncertain significance (Jul 18, 2022) | |||
X-11760863-G-A | Basilicata-Akhtar syndrome | Uncertain significance (Jun 30, 2021) | ||
X-11760875-C-G | Uncertain significance (Jan 01, 2023) | |||
X-11760913-G-A | MSL3-related disorder • Inborn genetic diseases | Likely benign (May 02, 2024) | ||
X-11760922-G-C | Basilicata-Akhtar syndrome | Uncertain significance (Jan 28, 2022) | ||
X-11761500-C-A | Basilicata-Akhtar syndrome | Pathogenic (Jun 10, 2024) | ||
X-11761501-A-G | Likely benign (Dec 01, 2021) | |||
X-11761513-C-T | MSL3-related disorder | Benign (Oct 22, 2019) | ||
X-11761531-C-G | MSL3-related disorder | Uncertain significance (Aug 29, 2023) | ||
X-11762130-AAAG-A | not specified | Uncertain significance (May 04, 2022) | ||
X-11762152-C-A | MSL3-related disorder | Uncertain significance (Feb 27, 2023) | ||
X-11762184-A-G | Inborn genetic diseases • MSL3-related disorder | Benign/Likely benign (Dec 01, 2023) | ||
X-11762211-C-T | Basilicata-Akhtar syndrome | Pathogenic (Jan 25, 2023) | ||
X-11762834-CAGTT-C | Basilicata-Akhtar syndrome | Pathogenic (Aug 07, 2022) | ||
X-11762855-C-T | Basilicata-Akhtar syndrome | Pathogenic (Dec 19, 2019) | ||
X-11762903-A-G | Inborn genetic diseases | Uncertain significance (Mar 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MSL3 | protein_coding | protein_coding | ENST00000312196 | 13 | 17593 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.997 | 0.00335 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.93 | 121 | 197 | 0.613 | 0.0000157 | 3439 |
Missense in Polyphen | 24 | 69.397 | 0.34584 | 1335 | ||
Synonymous | 0.672 | 63 | 70.2 | 0.898 | 0.00000554 | 942 |
Loss of Function | 3.80 | 0 | 16.8 | 0.00 | 0.00000113 | 351 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in chromatin remodeling and transcriptional regulation. May have a role in X inactivation. Component of the MSL complex which is responsible for the majority of histone H4 acetylation at 'Lys-16' which is implicated in the formation of higher-order chromatin structure. Specifically recognizes histone H4 monomethylated at 'Lys-20' (H4K20Me1) in a DNA-dependent manner and is proposed to be involved in chromosomal targeting of the MSL complex. {ECO:0000269|PubMed:16227571, ECO:0000269|PubMed:20018852, ECO:0000269|PubMed:20657587, ECO:0000269|PubMed:20943666, ECO:0000269|PubMed:21217699, ECO:0000269|PubMed:22547026}.;
- Pathway
- Chromatin modifying enzymes;HATs acetylate histones;Chromatin organization
(Consensus)
Recessive Scores
- pRec
- 0.0976
Intolerance Scores
- loftool
- rvis_EVS
- -0.23
- rvis_percentile_EVS
- 37.32
Haploinsufficiency Scores
- pHI
- 0.241
- hipred
- Y
- hipred_score
- 0.746
- ghis
- 0.528
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.872
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Msl3
- Phenotype
Gene ontology
- Biological process
- chromatin silencing;histone acetylation;histone deacetylation;histone H4 acetylation;histone H2A acetylation;histone H4-K16 acetylation
- Cellular component
- histone acetyltransferase complex;nucleoplasm;NuA4 histone acetyltransferase complex;MSL complex
- Molecular function
- DNA binding;methylated histone binding